Navigation Links
Closing the science-to-policy gap in maternal and child health in Africa
Date:6/29/2010

In the third of five papers in the PLoS Medicine series on maternal, neonatal, and child health in sub-Saharan Africa, Sara Bennett and Freddie Ssengooba this week discuss the challenges of getting science into policy in Africa. Dr Bennett, from Johns Hopkins University in Baltimore USA, and Dr Ssengooba from Makerere University in Uganda argue that that the technical basis for improving maternal, newborn, and child health (MNCH) in sub-Saharan Africa is largely known, but too often policy and practice are not well informed by science. Developing better policy networks in MNCH, mainstreaming the use of science in maternal, neonatal, and child health, and investing in innovative approaches to develop and applying such science are key, the authors say.

The authors conclude that "as we apply what we already know, we should continue to build institutional and individual capacity for the local adaptation and indigenization of global MNCH evidence to national and sub-national contexts, resources, and constraints."


'/>"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
Source:Eurekalert

Page: 1

Related medicine news :

1. Labopharm announces closing of US$20 million public offering of units
2. Sinovac Announces Closing of Common Share Offering
3. Mental Health Advocates and Community Providers Support Allentown State Hospital Closing
4. Disclosing sexual abuse is critical
5. Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions
6. Country action is needed for maternal and child health in Africa
7. Full reproductive and sexual health rights essential for maternal health goals
8. ADHD linked to low maternal education, lone parents and welfare benefits
9. Regional differences in C-section rate not a result of maternal request: UBC study
10. PeriGen Knowledge Summit to Address Issues in Maternal Healthcare
11. Demonstrated in vivo the transfer of maternal thyroid hormones to the fetus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... RU (PRWEB) , ... June 26, 2017 , ... ... released a whitepaper that pledges to solve many catastrophic issues within funding campaigns. ... 2017. , The typical notion of crowdfunding - the raising of funds through the ...
(Date:6/25/2017)... ... ... FCPX LUT Vintage Volume 2 for Final Cut Pro X allows users ... contains 60 different color-grade presets, giving editors multiple options for adding different color options. ... subjects, plus much more. FCPX LUT Vintage Volume 2 is designed for any skill-set ...
(Date:6/25/2017)... ... ... Republicans in the United States Senate on Thursday released their version of ... differs significantly from the American Health Care Act, which the House passed in May, ... will have to take up the Senate version as-is, if it passes. , The ...
(Date:6/25/2017)... ... , ... CareSet Labs released the Root NPI Graph today at the 2017 ... improved version of the Doctor Referral teaming dataset commonly available from Medicare. , Originally ... the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released by ...
(Date:6/25/2017)... ... 2017 , ... June is Men’s Health Month and the focus is on prostate ... in the U.S. and the third most common cause of cancer related death today; lung ... seven will be diagnosed with prostate cancer during his lifetime. Those at highest risk ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Novavax, Inc., (Nasdaq: NVAX ) today announced that ... its RSV F protein recombinant nanoparticle vaccine candidate (RSV F ... in the journal Vaccine (the data ... conferences). The Company previously announced top line results ... RSV F Vaccine with the goal of protecting infants from ...
(Date:6/5/2017)... , June 5, 2017 The ... brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded ... Cincinnati Enquirer . Results are based on an ... in organizational health and workplace improvement. The survey measures several ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: